MCOLN2 and breast carcinoma: In breast cancer, Huang et al. identified a 16-gene signature, including the Wnt/β-catenin signaling pathway and the MCOLN2 gene, associated with clinical ER and HER2 phenotype and recurrence, metastasis and distinct survival patterns [19].